Archives for April 12, 2018

Catalent completes $5.5m expansion to help serve large-scale clinical studies

The delivery technologies and development solutions provider Catalent Pharma Solutions today announced it has completed a $5.5m expansion program at its 200,000+ square foot Philadelphia, PA.

ClinOne latest to integrate with Lyft and Uber for patient transport

ClinOne is finalizing its integration with Lyft and Uber to provide clinical trial patients with free transportation services.

DCAT WEEK 2018

Pharma industry outlook: 80% of growth to come from pharmerging countries

China is becoming a fundamental player and is expected to reach market parity with the combined top five European countries by 2022, though the US still dominates, says industry expert.

With Ph IIb trials planned, PharmaCyte looks to revolutionize cancer treatment

PharmaCyte’s live-cell encapsulation technology could change the way solid tumor cancers are treated, says CEO, as the biotech moves forward with CRO selection ahead of its Ph IIb clinical trial – which will is expected to cost between $15 and $17m.

Falsified Medicines Directive: Assess CMO relationships now or pay the price later

Pharma must brace itself for production scheduling clashes and cost challenges ahead of next year’s Falsified Medicines Directive (FMD) says PharmSource.

ADENTS SERIALIZATION SUMMIT

Selling serialization data could help recuperate costs, says Medicines for Europe exec

Selling information from Europe’s national data repositories could help recover serialisation costs, says Medicines for Europe’s Johan Verhaeghe.

GSK offloads gene therapy portfolio and takes stake in Orchard

GlaxoSmithKline has sold a number of gene therapy products – including its approved autologous ex vivo product Strimvelis – to Orchard Therapeutics.